EX-23.1 10 fnch-ex23_1.htm EX-23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement No. 333-254773 on Form S-8 of our report dated March 31, 2022, relating to the consolidated financial statements of Finch Therapeutics Group, Inc. and its subsidiaries appearing in this Annual Report on Form 10-K of Finch Therapeutics Group, Inc. and its subsidiaries for the year ended December 31, 2021.

/s/ Deloitte & Touche LLP

Boston, Massachusetts

March 31, 2022